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SHORT COMMUNICATION

Effect of Zinc in Tablet and Suspension Formulations in The
Treatment of Acute Diarrhoea Among Young Children in
an Emergency Setting of Earthquake Affected
Region of Pakistan
Muhammad Atif Habib, Sajid Bashir Soofi and Zulfiqar A. Bhutta

ABSTRACT
A longitudinal cohort study was conducted at Camp Hospital Batagram in August 2006 to ascertain the effect of Zinc
utilization in tablet and suspension formulations on the frequency and recovery rates of diarrhoea among young children
in the emergency settings of earthquake affected region of Pakistan. Two hundred patients were recruited and followedup, the patients were allocated either of the 2 groups i.e. A (Zinc in tablets form) and B (Zinc in suspension form). Both
groups also received WHO recommended treatment for diarrhoea. Most of the cases recovered from the illness within 3
days after presentation. Significant p-values were established among Zinc use and reduction in frequency of stools on Day
2 and 3, with better outcome in group B. The study supports the notion that Zinc reduces the frequency and improves
recovery rates of diarrhoea in any form and has better compliance and outcomes with the use in suspension form.
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Diarrhoeal diseases are still the major paediatric health
concern worldwide which contributes to 2.5 million
annual deaths in children.1 The therapy of using Oral
Rehydration Solution (ORS) and nutritional management are considered to be the best choice for the
management of diarrhoea in young children.2 The ORS
reduces the risk of mortality by averting the dehydration
but it does not help in reducing the frequency and
consistency of stools.3
Zinc supplementation along with ORS has emerged as
a potent approach to treat diarrhoea and studies have
endorsed the fact that use of Zinc is associated with a
significant reduction in duration of diarrhoea.4,5 The
World Health Organization (WHO) also recommended
daily Zinc supplements for 10-14 days for children with
acute diarrhoea. However, there are still some enduring
gaps in the information about dose and intake of Zinc
supplementation, it is not clear what form of Zinc is more
acceptable and effective.
A longitudinal cohort study was conducted among children
to measure the impact of daily Zinc administration in
different formulations. There were two groups in the
study; one group received Zinc in the form of suspension
whereas the other group received Zinc in the form of
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dispersible tablets. Zinc was given in a dose of 3 RDA
(1 RDA = 5 mg per day for infant and 10 mg per day
for children) as per standard recommendations. The
standard WHO treatment for the management of acute
diarrhoea was also provided to the enrolled cases.
A sample size of 200 patients was calculated assuming
80% Power, 95% CI and 20% Improved recovery rates,
by using the approximate sample size formula. The
enrolled children were brought to the hospital with acute
gastroenteritis both from inpatient and outpatient units.
Diarrhoea was defined as the passage of 3 or more
loose or watery stools in the 24-hour period before
enrolment. Eligible children were screened by a
physician and recruited in the study, after the screening
a verbal consent was obtained from the parents or
caretaker and the patient was randomized in one of the
two groups. Children were randomized either of the 2
intervention using block randomization.
Patients were examined and daily information on
morbidity and general health at the time of recruitment
and on follow-up days 1, 2 and 3 was recorded. Followups were done only for 3 days due to limited resources,
short stay of patients at Camp Hospital and reluctance
of patient to come back for follow-up. Data was collected
on illness characteristics, frequency of stools and
vomiting, hydration status and the use of the supplement
per day since the last visit was noted. Compliance was
measured by reported intake and by measuring the
remaining volume of syrup in the returned bottles and
tablets in the strips respectively.
Data was entered in Visual FoxPro version 7 and statistical
analysis was conducted using SPSS 14 (SPSS Inc.

Journal of the College of Physicians and Surgeons Pakistan 2010, Vol. 20 (12): 837-838

837

Muhammad Atif Habib, Sajid Bashir Soofi and Zulfiqar A. Bhutta

Chicago, IL, USA). Mean and standard deviation were
calculated for continuous variables and frequency and
percentages were computed for categorical variables.
Chi-square test was used to see association among
categorical variables.

Table I: Day wise diarrhoea recovery rates.

Day 1
Day 2

The baseline characteristics of the patients in both
groups were similar. All the cases were recruited in the
study and randomized in one of the two groups to
receive the Zinc formulation along with the conventional
treatment of diarrhoea. It was intended to treat all the
cases with Zinc suspension but 15% of cases were
dropped out during the study and could not receive the
Zinc formulations. Those cases were excluded from
analysis because the compliance of Zinc could not be
analysed on them. So the effectiveness of Zinc
formulations were analysed among 190 cases, 81 and
109 respectively in group A and B. The main reasons for
the drop outs were cultural beliefs, left against medical
advice, referrals and refusal for the treatment.

Day 3

Total
48
26.1%
129
70.1%
164
89.1%

p-value

RR (95% CI of RR)

0.06

1.17 (0.99-1.39)

0.001

2.04 (1.3-3.21)

0.001

4.76 (1.63-13.90)

The study supports the fact that Zinc is beneficial in the
treatment of acute diarrhoea and can help in reduction
of morbidity and mortality associated with diarrhoeal
illnesses. Moreover, it explores the use of Zinc in
different formulations and delivery mechanism and
supports the suspension form. It appears that the
suspension form is more easy and handy to use
especially in emergency settings. But the cost of syrups
may possibly limit its use as the conventional treatment
of diarrhoea. But before establishing any conclusion
more controlled studies and trials are needed to
establish more evidence in favour of Zinc suspension.
Specific suggestion concerning the utilization of Zinc
supplementation in any kind of supplementation for the
treatment of acute diarrhoea must look forward to further
population-based studies measuring the role of Zinc
supplementation in diverse formulations for the treatment of acute diarrhoea.
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